Delivery Order SPE2DB24D9144-SPE2DB24FCMJJ
Award Date
8/5/24
Potential Completion Date
8/26/24
Potential Value
$7.7K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order with a ceiling value of $7,737.00. The contract is for the delivery of Xolair 150 mg/ml syringes and is placed under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) valued at $499,999,999. The IDC, awarded under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $38,685.00. The award was made by the Defense Logistics Agency (DLA) under the SPE2DB program, which is an indefinite delivery contract valued up to $499,999,999 that runs through December 31, 2025. This contract allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $7,737.00 for the supply of XOLAIR 150 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), which is the primary logistics and supply agency for the U.S. Department of Defense. The contract has an ultimate completion date of March 4, 2025 and is a firm fixed-price delivery order, with no set-aside designation. DMS Pharmaceutical Group Inc. holds...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $9,671.25 firm fixed-price delivery order is for the pharmaceutical product XOLAIR 150 MG/ML SYRINGEML, with a completion date of June 4, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order worth $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to...
The Defense Logistics Agency (DLA) awarded a $27,853.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Xolair 150 mg/ml syringes. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order worth $3,094.80 under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The contract is for the supply of Xolair 150 mg/ml syringes, a specialty pharmaceutical product. The SPE2DB IDC is a single-award contract valued at up to $499,999,999 that allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $5,136.69 for the supply of the drug Xolair 300 mg/2 ml autoinjector. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 28, 2024. This award is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $3,094.80, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order with a ceiling value of $6,189.60. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract is for the delivery of Xolair 150 mg/ml syringes, a specialized pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. This order is part of a larger indefinite delivery contract (IDC)...